Millions on Medicaid May Soon Have To Prove They’re Working To Keep Coverage

The Trump administration has published new rules on who can qualify for Medicaid coverage, including requirements that many recipients work or attend school.

The requirements state that Medicaid recipients who are not exempt must prove they spent at least 80 hours per month working, performing community service or going to school at least ...

Just 90 Minutes Of Strength Training A Week Linked To Longer Life

A few sessions in the weight room each week could do more than build muscle — they may help you live longer.

While the evidence linking aerobic exercise to longevity is extensive, little is known about the effects of strength training.

In a study recently published in the British Journal of Sports Medicine, researchers...

Urine Test Can Detect Autism, Study Says

A simple urine test might help identify children who are likely to have autism earlier than the best assessment tools now available, a new study says.

Autistic children appear to have specific gut microbe profiles that can be used to distinguish them from neurotypical (or typically developing) children, researchers reported May 26 in the j...

High-Puff Vapes Become More Toxic Over Time, Study Says

E-cigarettes that offer a lot of extra puffs might become more toxic the longer they are used, a new study says.

High-puff vapes can typically deliver into the thousands of inhalations before they run out, because they hold more e-liquid and are designed for extended use, researchers said.

But toxic chemicals called aldehydes start b...

Chemo-Free Drug Shows Major Survival, Remission Gains In Relapsed Multiple Myeloma

A recently approved cancer immunotherapy can put nearly two-thirds of people with relapsed multiple myeloma into complete remission, a new clinical trial has found.

About 70% of patients treated with teclistamab (Tecvayli) achieved 18 months without any progression of their cancer, compared to about 27% who received standard treatment, res...

GLP-1 Drugs Like Ozempic May Lower Breast Cancer Risk By About 30%

Taking Ozempic or Zepbound might lower a woman’s risk of breast cancer, a new study says.

Women with excess weight taking GLP-1 drugs were about 30% less likely to develop breast cancer than those not taking such medications, researchers reported June 2 in the journal JCO Oncology Practice.

“While our study was o...